1. Home
  2. FIHL vs SRPT Comparison

FIHL vs SRPT Comparison

Compare FIHL & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FIHL
  • SRPT
  • Stock Information
  • Founded
  • FIHL 2014
  • SRPT 1980
  • Country
  • FIHL Bermuda
  • SRPT United States
  • Employees
  • FIHL N/A
  • SRPT N/A
  • Industry
  • FIHL
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FIHL
  • SRPT Health Care
  • Exchange
  • FIHL Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • FIHL 1.8B
  • SRPT 1.9B
  • IPO Year
  • FIHL 2023
  • SRPT 1997
  • Fundamental
  • Price
  • FIHL $18.09
  • SRPT $22.64
  • Analyst Decision
  • FIHL Hold
  • SRPT Hold
  • Analyst Count
  • FIHL 7
  • SRPT 31
  • Target Price
  • FIHL $20.43
  • SRPT $40.61
  • AVG Volume (30 Days)
  • FIHL 506.0K
  • SRPT 6.4M
  • Earning Date
  • FIHL 11-11-2025
  • SRPT 11-05-2025
  • Dividend Yield
  • FIHL 3.31%
  • SRPT N/A
  • EPS Growth
  • FIHL N/A
  • SRPT N/A
  • EPS
  • FIHL N/A
  • SRPT N/A
  • Revenue
  • FIHL $2,607,600,000.00
  • SRPT $2,481,531,000.00
  • Revenue This Year
  • FIHL $21.24
  • SRPT $9.41
  • Revenue Next Year
  • FIHL $5.01
  • SRPT N/A
  • P/E Ratio
  • FIHL N/A
  • SRPT N/A
  • Revenue Growth
  • FIHL 21.21
  • SRPT 64.89
  • 52 Week Low
  • FIHL $14.17
  • SRPT $10.42
  • 52 Week High
  • FIHL $21.32
  • SRPT $138.81
  • Technical
  • Relative Strength Index (RSI)
  • FIHL 60.66
  • SRPT 68.62
  • Support Level
  • FIHL $16.96
  • SRPT $17.57
  • Resistance Level
  • FIHL $18.60
  • SRPT $23.42
  • Average True Range (ATR)
  • FIHL 0.50
  • SRPT 1.32
  • MACD
  • FIHL 0.03
  • SRPT 0.52
  • Stochastic Oscillator
  • FIHL 69.09
  • SRPT 87.76

About FIHL Fidelis Insurance Holdings Limited

Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: